|
Kampman, Kyle; Majewska, Maria Dorota; Tourian, Karen et al. (2003) A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addict Behav 28:437-48
|
|
Kampman, Kyle M; Volpicelli, Joseph R; Mulvaney, Frank et al. (2002) Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav 27:251-60
|
|
Kampman, K M; Alterman, A I; Volpicelli, J R et al. (2001) Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav 15:52-9
|
|
Kampman, K M; Volpicelli, J R; Mulvaney, F et al. (2001) Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend 63:69-78
|
|
Kampman, K M; Rukstalis, M; Pettinati, H et al. (2000) The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial. J Subst Abuse Treat 19:77-9
|
|
Kampman, K M; Rukstalis, M; Ehrman, R et al. (1999) Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence. Addict Behav 24:287-91
|
